MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $229 | -42.0% | 6,350 | -40.2% | 0.02% | -59.5% |
| Q1 2023 | $395 | -99.9% | 10,623 | +12.7% | 0.04% | -30.0% |
| Q3 2022 | $658,000 | -2.7% | 9,423 | -6.4% | 0.06% | +5.3% |
| Q2 2022 | $676,000 | -45.0% | 10,070 | +32.4% | 0.06% | -52.1% |
| Q2 2021 | $1,229,000 | +196.9% | 7,607 | +303.3% | 0.12% | +164.4% |
| Q4 2020 | $414,000 | -46.1% | 1,886 | -59.2% | 0.04% | -65.9% |
| Q3 2020 | $768,000 | +161.2% | 4,627 | +22.5% | 0.13% | +473.9% |
| Q3 2019 | $294,000 | +12.6% | 3,776 | +6.1% | 0.02% | +53.3% |
| Q1 2019 | $261,000 | – | 3,558 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |